Global Precision Medicine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Precision Medicine market size will reach 166,520 Million USD in 2025 and is projected to reach 311,314 Million USD by 2032, with a CAGR of 9.35% (2025-2032). Notably, the China Precision Medicine market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Precision medicine, also known as personalized medicine, is an innovative approach to healthcare that takes into account individual differences in patients＇ genes, environments, and lifestyles. The aim of precision medicine is to tailor medical care and treatment plans to the specific characteristics of each patient, allowing for more accurate and effective interventions. Advances in genomics and molecular biology have played a crucial role in the development of precision medicine by providing insights into the genetic makeup of individuals and their susceptibility to certain diseases. This approach enables healthcare professionals to make data-driven decisions about prevention, diagnosis, and treatment, considering the unique genetic and molecular profiles of patients. Precision medicine holds the promise of improving patient outcomes, minimizing adverse effects, and optimizing the overall efficiency of healthcare by moving away from a one-size-fits-all model to a more individualized and targeted approach.
The major global suppliers of Precision Medicine include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, GE Healthcare, Illumina, Intel Corporation, bioMérieux, Cepheid, Qiagen, IBM, Thermo Fisher Scientific, Randox Laboratories, Almac Group, HealthCore Physicians Group, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Precision Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Precision Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Precision Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Precision Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Precision Medicine Include:
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
GE Healthcare
Illumina
Intel Corporation
bioMérieux
Cepheid
Qiagen
IBM
Thermo Fisher Scientific
Randox Laboratories
Almac Group
HealthCore Physicians Group
Precision Medicine Product Segment Include:
Precision Diagnostics
Precision Therapies
Precision Medicine Product Application Include:
Oncology
Neurosciences
Immunology
Respiratory
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Precision Medicine Industry PESTEL Analysis
Chapter 3: Global Precision Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Precision Medicine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Precision Medicine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Precision Medicine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Precision Medicine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Precision Medicine market size will reach 166,520 Million USD in 2025 and is projected to reach 311,314 Million USD by 2032, with a CAGR of 9.35% (2025-2032). Notably, the China Precision Medicine market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Precision medicine, also known as personalized medicine, is an innovative approach to healthcare that takes into account individual differences in patients＇ genes, environments, and lifestyles. The aim of precision medicine is to tailor medical care and treatment plans to the specific characteristics of each patient, allowing for more accurate and effective interventions. Advances in genomics and molecular biology have played a crucial role in the development of precision medicine by providing insights into the genetic makeup of individuals and their susceptibility to certain diseases. This approach enables healthcare professionals to make data-driven decisions about prevention, diagnosis, and treatment, considering the unique genetic and molecular profiles of patients. Precision medicine holds the promise of improving patient outcomes, minimizing adverse effects, and optimizing the overall efficiency of healthcare by moving away from a one-size-fits-all model to a more individualized and targeted approach.
The major global suppliers of Precision Medicine include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, GE Healthcare, Illumina, Intel Corporation, bioMérieux, Cepheid, Qiagen, IBM, Thermo Fisher Scientific, Randox Laboratories, Almac Group, HealthCore Physicians Group, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Precision Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Precision Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Precision Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Precision Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Precision Medicine Include:
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
GE Healthcare
Illumina
Intel Corporation
bioMérieux
Cepheid
Qiagen
IBM
Thermo Fisher Scientific
Randox Laboratories
Almac Group
HealthCore Physicians Group
Precision Medicine Product Segment Include:
Precision Diagnostics
Precision Therapies
Precision Medicine Product Application Include:
Oncology
Neurosciences
Immunology
Respiratory
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Precision Medicine Industry PESTEL Analysis
Chapter 3: Global Precision Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Precision Medicine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Precision Medicine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Precision Medicine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Precision Medicine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Precision Medicine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Precision Medicine Product by Type
- 1.2.1 Precision Diagnostics
- 1.2.2 Precision Therapies
- 1.3 Precision Medicine Product by Application
- 1.3.1 Oncology
- 1.3.2 Neurosciences
- 1.3.3 Immunology
- 1.3.4 Respiratory
- 1.3.5 Others
- 1.4 Global Precision Medicine Market Size Analysis (2020-2032)
- 1.5 Precision Medicine Market Development Status and Trends
- 1.5.1 Precision Medicine Industry Development Status Analysis
- 1.5.2 Precision Medicine Industry Development Trends Analysis
- 2 Precision Medicine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Precision Medicine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Precision Medicine Market Analysis by Country
- 4.1 Global Precision Medicine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Precision Medicine Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Precision Medicine Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.5 China Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.6 France Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.14 India Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Precision Medicine Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Precision Medicine Market Revenue by Key Suppliers (2021-2025)
- 5.2 Precision Medicine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Precision Medicine Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Precision Medicine Market Analysis by Type
- 6.1 Global Precision Medicine Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Precision Medicine Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Johnson & Johnson
- 7.1.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Johnson & Johnson Precision Medicine Product Portfolio
- 7.1.3 Johnson & Johnson Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Roche
- 7.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Roche Precision Medicine Product Portfolio
- 7.2.3 Roche Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Labcorp
- 7.3.1 Labcorp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Labcorp Precision Medicine Product Portfolio
- 7.3.3 Labcorp Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Abbott Laboratories
- 7.4.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Abbott Laboratories Precision Medicine Product Portfolio
- 7.4.3 Abbott Laboratories Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Novartis
- 7.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Novartis Precision Medicine Product Portfolio
- 7.5.3 Novartis Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 GE Healthcare
- 7.6.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 GE Healthcare Precision Medicine Product Portfolio
- 7.6.3 GE Healthcare Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Illumina
- 7.7.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Illumina Precision Medicine Product Portfolio
- 7.7.3 Illumina Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Intel Corporation
- 7.8.1 Intel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Intel Corporation Precision Medicine Product Portfolio
- 7.8.3 Intel Corporation Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 bioMérieux
- 7.9.1 bioMérieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 bioMérieux Precision Medicine Product Portfolio
- 7.9.3 bioMérieux Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Cepheid
- 7.10.1 Cepheid Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Cepheid Precision Medicine Product Portfolio
- 7.10.3 Cepheid Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Qiagen
- 7.11.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Qiagen Precision Medicine Product Portfolio
- 7.11.3 Qiagen Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 IBM
- 7.12.1 IBM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 IBM Precision Medicine Product Portfolio
- 7.12.3 IBM Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Thermo Fisher Scientific
- 7.13.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Thermo Fisher Scientific Precision Medicine Product Portfolio
- 7.13.3 Thermo Fisher Scientific Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Randox Laboratories
- 7.14.1 Randox Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Randox Laboratories Precision Medicine Product Portfolio
- 7.14.3 Randox Laboratories Precision Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Almac Group
- 7.15.1 Almac Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Almac Group P
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
